Loading clinical trials...
Loading clinical trials...
68Ga labeled Claudin 18.2 contrast agent combined with PET/CT for gastric or gastroesophageal junction
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
SmartNuclide Biopharma
NCT06388967 · Pancreatic Cancer, Pancreatic Carcinoma, and more
NCT05254171 · Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, and more
NCT05715931 · Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, and more
NCT05872685 · Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, and more
NCT05729646 · Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, and more
The First Affiliated Hospital of Soochow University
Jiangsu, Province
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions